BioSpace News Archive

Olympus announced its support of the new recommendation issued by the United States Preventive Services Task Force to begin colorectal cancer screenings for all individuals beginning at age 45.

Adlon Therapeutics L.P. announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) to update the prescribing information for Adhansia XR.

Black Bird Biotech, Inc. today announced that it has submitted its application to uplist to the OTCQB Venture Market.

Veracyte hat expand and further strengthen the company’s medical team. William A. Bulman, M.D. and Paul Kelly Marcom, M.D, have joined the company as medical director for Lung Cancer and medical director for Breast Cancer, respectively.

BioGX, a global provider of molecular diagnostic solutions, announced that the United States Food and Drug Administration has issued Emergency Use Authorization (EUA) for their breakthrough direct sample addition, Xfree™ COVID-19 test.

Korea National Institute of Health, Korea’s top research center in the field of hygiene and medicine conducted a field inspection of key companies with mRNA technology.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today provided a business update.

Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to be used as a companion diagnostic for ALUNBRIG® (brigatinib), which is currently FDA-approved for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.

Maja brings deep knowledge and experience from different functions within finance and management, in the life science industry.

Arete Pharmacy Network, LLC, and Pharmacy Providers of Oklahoma, Inc. announced that they have signed a definitive agreement to create AlignRx, a pharmacy services administrative organization strategically aligned with the needs of a continuously evolving pharmacy landscape.